DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
August 22, 2022 10:40 ET
|
DoubleRainbow Biosciences
Lexington, MA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health,...
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
August 15, 2022 23:41 ET
|
Endure Biotherapeutics, Inc.
San Diego, Aug. 15, 2022 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics Zarrinpar...
Senior communications leader joins Manus Bio
August 11, 2022 12:08 ET
|
Manus Bio
BOSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Manus Bio, the leading biomanufacturer of natural products, has appointed Frederik Bjoerndal as its Vice President of Corporate Communications. Frederik...
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022 06:58 ET
|
Synlogic, Inc.
– Three clinical data readouts across three programs expected in H2 2022 – – PKU Phase 3 readiness activities underway for planned start in H1 2023 – – $106.8 million in cash, cash equivalents and...
Synthetic Biology Market Global Outlook and Forecast 2022-2027: Synthetic Biology Brings a Paradigm Shift in the Field of Biomedicine and With it Lucrative Growth Opportunities
August 09, 2022 07:13 ET
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global synthetic...
Synlogic Announces Second Quarter 2022 Conference Call and Webcast
July 28, 2022 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Global Synthetic Biology Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
July 15, 2022 05:03 ET
|
Research and Markets
Dublin, July 15, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria (HCU)
July 12, 2022 07:00 ET
|
Synlogic, Inc.
Expected data in H2 2022 brings Synlogic to three clinical readouts this year Third candidate in less than two years to enter the clinic; Reflects productivity of Synthetic Biotic platform ...
Synlogic Announces Appointment of General Counsel and Corporate Secretary
June 29, 2022 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., June 29, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic to Present at the 2022 HCU Network America, Organic Acidemia Association and Propionic Acidemia Foundation Conference
June 21, 2022 07:00 ET
|
Synlogic, Inc.
BETHESDA, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...